New Cancer Drug Reboots Stalled Immunotherapies
Published in
2 min readNov 2, 2020
In contrast to traditional chemotherapies, immunotherapies reprogram the patient’s own immune system to fight tumor cells. The hope is that these types of treatments will be more effective at permanently eliminating cancer cells and have fewer side effects due to their more targeted nature. However, clinical testing of immunotherapeutics has revealed that certain types of malignancies are resistant to…